Fideicomiso Irrevocable 4594

As of June 30, 2024, Fideicomiso Irrevocable 4594 carries a market capitalization of 66.06M, placing it among publicly traded companies globally. Its enterprise value stands at -6.35B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2024, Fideicomiso Irrevocable 4594 has 2.54M shares outstanding.

As of June 30, 2024, Fideicomiso Irrevocable 4594 trades at a trailing price-to-earnings ratio of 71.90. The price-to-sales ratio is 10.74, and the price-to-book ratio stands at 0.01.

These figures are as of June 30, 2024.

Over the twelve months ended June 30, 2024, Fideicomiso Irrevocable 4594 posted a return on equity (ROE) of 10.88, showing how much profit the company earns on every dollar of shareholder capital. Return on assets (ROA) stands at 1.15, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 10.08, useful for judging operating efficiency across full business cycles.

Over the twelve months ended June 30, 2024, Fideicomiso Irrevocable 4594 recorded 206.81M in income tax expense. That works out to an effective tax rate of 25.23, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 819.66M, leaving 612.85M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on August 20, 2026, Fideicomiso Irrevocable 4594's stock has gained approximately 0.00% over the past 52 weeks.

Over the twelve months ended June 30, 2024, Fideicomiso Irrevocable 4594 generated 4.10B in revenue and converted that into 612.85M in net income, yielding earnings per share of 0.36.

As of June 30, 2024, Fideicomiso Irrevocable 4594 holds 6.82B in cash and equivalents against 400.64M in total debt, resulting in a net debt position of -6.82B.

Fideicomiso Irrevocable 4594 produced -1.12B in operating cash flow over the twelve months ended June 30, 2024. After subtracting -101.00M in capital expenditures, free cash flow totaled -1.22B - equivalent to -0.72 per share.

These figures cover the twelve months ended June 30, 2024.

These figures cover the twelve months ended June 30, 2024. Free cash flow yield is negative at -2.76: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -728.17, meaning Fideicomiso Irrevocable 4594 raised more capital through share issuance and new debt than it returned via dividends and buybacks.